Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche’s Good Cholesterol Drug Shows Negative Side Effects
Bloomberg
Monday, November 5, 2012 - 4:59pm
tags:
Roche, dalcetrapib, CETP inhibitors
What Will The FDA Look Like After The Election?
Pharmalot
Monday, November 5, 2012 - 1:03pm
tags:
FDA
Omeros' OMS302 successful in second Phase 3 clinical trial
Yahoo/Fly on the Wall
Monday, November 5, 2012 - 1:00pm
tags:
Omeros, OMS302, intraocular lens replacement surgery
BioMarin at life-high as genetic disorder drug meets main goal
Reuters
Monday, November 5, 2012 - 12:58pm
tags:
Biomarin, GALNs, Morquio A Syndrome
Chelsea Therapeutics Intl Third Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Monday, November 5, 2012 - 12:56pm
tags:
earnings, Chelsea Therapeutics
Pluristem Standardizes Stem Cell Therapy, Opening Door To The Future Of Medicine
Seeking Alpha
Monday, November 5, 2012 - 12:49pm
tags:
Pluristem, stem cells, Mesoblast, Osiris, Thermo Fisher
Repligen Corp Third Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Monday, November 5, 2012 - 12:48pm
tags:
Repligen, earnings
3 Things to Watch With Spectrum's Earnings
Motley Fool
Monday, November 5, 2012 - 12:47pm
tags:
earnings, Spectrum Pharmaceuticals
Pharmacyclics slumps on disappointing study data
Yahoo/AP
Monday, November 5, 2012 - 12:45pm
tags:
Pharmacyclics, ibrutinib, JNJ, lymphoma, leukemia
NovaBay: Potential Of NVC-422 For Treating Impetigo Is Key Factor In Recent Long Recommendation
Seeking Alpha
Monday, November 5, 2012 - 11:32am
tags:
NovaBay, NVC-422, impetigo
Teva Pharmaceuticals: Valuation Is Too Depressed On Worries About Copaxone
Seeking Alpha
Monday, November 5, 2012 - 11:30am
tags:
Teva, Copaxone, MS, multiple sclerosis
Endo's quarterly results miss estimates, cuts full-year outlook
Reuters
Monday, November 5, 2012 - 11:28am
tags:
Endo, earnings
Teva says Marth to step down as CEO of Teva Americas
Reuters
Monday, November 5, 2012 - 11:26am
tags:
Teva Pharmaceuticals, Pharma CEOs, William Marth
Novartis mulls investment in Malaysia
Business Times
Monday, November 5, 2012 - 11:24am
tags:
Malaysia, Novartis
India Revokes Patent On Roche Hepatitis C Drug
Pharmalot
Monday, November 5, 2012 - 11:22am
tags:
India, patents, Roche, hepatitis C, Pegasys
Arena Pharmaceuticals' Solution to a Billion Dollar a Day Problem
Motley Fool
Monday, November 5, 2012 - 11:15am
tags:
Arena Pharmaceuticals, obesity, Belviq
Is Big Pharma Dangerously Betting on Huge, Fragile Product Shots?
Forbes
Monday, November 5, 2012 - 11:15am
tags:
Big Pharma, Sanofi
FDA Confirms Necessity of Ventrus' Second Phase III
Yahoo/Reuters
Monday, November 5, 2012 - 11:13am
tags:
FDA, Ventrus, anal fissures, VEN-307
Abbott Said to Plan Benchmark Bond Offering for AbbVie Spinoff
Bloomberg
Monday, November 5, 2012 - 11:06am
tags:
Abbott Labs, AbbVie, bonds
Regeneron, Sanofi Take Step Forward With Cholesterol Drug
Minyanville
Monday, November 5, 2012 - 11:05am
tags:
Regeneron, Sanofi, PCSK9, LDL cholesterol, Amgen, AMG145, SAR236553/REGN727

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.